Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa
暂无分享,去创建一个
[1] T. Bottiglieri. Folate, vitamin B12, and neuropsychiatric disorders. , 2009, Nutrition reviews.
[2] J. Iwamoto,et al. Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease. , 2005, The American journal of medicine.
[3] G. De Sarro,et al. Increase in plasma homocysteine levels induced by drug treatments in neurologic patients. , 2005, Pharmacological research.
[4] J. Burnett,et al. Alcohol-associated severe hyperhomocysteinaemia , 2005, Annals of clinical biochemistry.
[5] A. Hofman,et al. Methylenetetrahydrofolate reductase C677T genotype and PD , 2005, Annals of neurology.
[6] J. Rodés,et al. Prevalence and mechanisms of hyperhomocysteinemia in chronic alcoholics. , 2005, Alcoholism, clinical and experimental research.
[7] P. Livrea,et al. Hyperhomocysteinemia in l‐dopa treated Parkinson's disease patients: effect of cobalamin and folate administration , 2005, European journal of neurology.
[8] S. Westphal,et al. Effect of drugs on homocysteine concentrations. , 2005, Seminars in vascular medicine.
[9] H. Hendriks,et al. Kinetics of homocysteine metabolism after moderate alcohol consumption. , 2005, Alcoholism, clinical and experimental research.
[10] P. Livrea,et al. Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications. , 2005, Parkinsonism & related disorders.
[11] P. O'Suilleabhain,et al. Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.
[12] A. Chetrit,et al. Life-style habits and homocysteine levels in an elderly population , 2004, Aging clinical and experimental research.
[13] D. Panagiotakos,et al. Effect of interaction between adherence to a Mediterranean diet and the methylenetetrahydrofolate reductase 677C-->T mutation on homocysteine concentrations in healthy adults: the ATTICA Study. , 2004, The American journal of clinical nutrition.
[14] A. Lang,et al. Homocysteine and levodopa , 2004, Neurology.
[15] J. Pérez-Castrillón,et al. Homocysteine as a predictive factor for hip fracture in older persons. , 2004, The New England journal of medicine.
[16] L. Husemoen,et al. Effect of lifestyle factors on plasma total homocysteine concentrations in relation to MTHFR(C677T) genotype. Inter99 (7) , 2004, European Journal of Clinical Nutrition.
[17] A. Siniscalchi. [Hyperhomocysteinemia in neurologic diseases]. , 2004, Recenti progressi in medicina.
[18] P. O'Suilleabhain,et al. Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations. , 2004, Archives of neurology.
[19] A. Hofman,et al. Homocysteine levels and the risk of osteoporotic fracture. , 2004, The New England journal of medicine.
[20] S. Vollset,et al. Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study. , 2004, The American journal of clinical nutrition.
[21] M. Katan,et al. A healthy lifestyle lowers homocysteine, but should we care? , 2004, The American journal of clinical nutrition.
[22] A. Di Rocco,et al. Effect of l-dopa on plasma homocysteine in PD patients: Relationship to B-vitamin status , 2004, Neurology.
[23] D. Nyholm,et al. New developments in levodopa therapy , 2004, Neurology.
[24] K. Nakashima,et al. Levodopa‐induced hyperhomocysteinaemia in Parkinson's disease , 2003, Acta neurologica Scandinavica.
[25] Jiang He,et al. Relationship between Cigarette Smoking and Novel Risk Factors for Cardiovascular Disease in the United States , 2003, Annals of Internal Medicine.
[26] D. Woitalla,et al. Benefit of folic acid supplementation in parkinsonian patients treated with levodopa , 2003, Journal of neurology, neurosurgery, and psychiatry.
[27] K. Nakashima,et al. Hypertrophy of IMC of carotid artery in Parkinson's disease is associated with l-DOPA, homocysteine, and MTHFR genotype , 2003, Journal of the Neurological Sciences.
[28] H. Blom,et al. Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease , 2002, Pharmacological Reviews.
[29] T. Müller,et al. Dopaminergic substitution in Parkinson’s disease , 2002, Expert opinion on pharmacotherapy.
[30] D. Cook,et al. Homocysteine levels in men and women of different ethnic and cultural background living in England. , 2002, Atherosclerosis.
[31] M. Mattson,et al. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease , 2002, Journal of neurochemistry.
[32] D. Wald,et al. Randomized trial of folic acid supplementation and serum homocysteine levels. , 2001, Archives of internal medicine.
[33] G. Coetzee,et al. Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. , 2001, The American journal of clinical nutrition.
[34] Yoshihiro Sato,et al. Risk factors for hip fracture among elderly patients with Parkinson’s disease , 2001, Journal of the Neurological Sciences.
[35] M. Katan,et al. Heavy coffee consumption and plasma homocysteine: a randomized controlled trial in healthy volunteers. , 2000, The American journal of clinical nutrition.
[36] R. Diaz-Arrastia,et al. Homocysteine and neurologic disease. , 2000, Archives of neurology.
[37] P. Finglas. Dietary Reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline , 2000 .
[38] L. Wang,et al. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. , 2000, Molecular genetics and metabolism.
[39] I. Ziv,et al. Levodopa – an exotoxin or a therapeutic drug? , 2000, Journal of Neurology.
[40] R. D'Agostino,et al. Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study , 1999, Annals of Internal Medicine.
[41] M. Hennerici,et al. Homocysteine in cerebral macroangiography and microangiopathy , 1999, The Lancet.
[42] H. Blom,et al. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials , 1998, BMJ.
[43] I. Crombie. Book Review: Non-Random Reflections on Health Services Research , 1997 .
[44] J. Selhub,et al. The effect of L-dopa administration and folate deficiency on plasma homocysteine concentrations in rats , 1997 .
[45] B. Shukitt-Hale,et al. Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats. , 1997, Clinical neuropharmacology.
[46] A. Spiro,et al. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. , 1996, The American journal of clinical nutrition.
[47] S. Vollset,et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. , 1995, JAMA.
[48] K. Perry,et al. Tropolone antagonism of the l−dopa‐induced elevation of S‐adenosylhomocysteine: S‐adenosylmethionine ratio but not depletion of adrenaline in rat hypothalamus , 1984, The Journal of pharmacy and pharmacology.
[49] J. Aita,et al. Why patients with Parkinson's disease fall. , 1982, JAMA.
[50] H. Taufek,et al. Influence of exogenous L-3,4,-dihydroxyphenylalanine (L-dopa) on the methionine and s-adenosylmethionine concentrations in the brain and other tissues [proceedings]. , 1980, Biochemical Society transactions.
[51] R. Wurtman,et al. Folic acid deficiency and methyl group metabolism in rat brain: effects of L-dopa. , 1974, Archives of Biochemistry and Biophysics.
[52] G. Defazio,et al. Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions , 2005, Clinical chemistry and laboratory medicine.
[53] D. Woitalla,et al. MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson's disease. , 2004, Journal of neural transmission. Supplementum.
[54] R. Diaz-Arrastia,et al. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. , 2003, Archives of neurology.
[55] R. Steegers-Theunissen,et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial 1–3 , 2022 .
[56] J. Selhub,et al. Homocysteine and thrombotic disease. , 1997, Blood.
[57] J. Selhub,et al. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. , 1992, The American journal of clinical nutrition.